The IMA Group Acquires PsyBar

The IMA Group Acquires EVOnational

February 23, 2021

Healthcare Services

The IMA Group, a technology-driven provider of medical and psychological evaluations, has acquired EVOnational, a national provider of independent medical exams (IMEs), medical screenings and other evaluations. The acquisition — terms not disclosed — adds more than 7,000 clinicians to IMA's provider panel, expands IMA's behavioral and medical evaluation capabilities, and will see EVOnational continue to operate under its current name with existing leadership retained.

The IMA Group Acquires MedPlus Disability Evaluations

August 17, 2021

Healthcare Services

The IMA Group, a technology-enabled provider of medical and psychological screening and evaluation services, has acquired MedPlus Disability Evaluations, a regional provider of Social Security Disability consultative examinations. The acquisition expands IMA's geographic footprint by adding MedPlus's operations across an additional seven states and broadens IMA's portfolio of disability and specialty evaluation services.

The IMA Group Acquires Pontum Health

June 6, 2023

Healthcare Services

The IMA Group has acquired Pontum Health, a Seattle‑area provider of Social Security Disability and related consultative evaluations. The acquisition extends IMA's Evaluation Services coverage further into the Pacific Northwest—adding Alaska and Oregon and strengthening presence in Washington—while Pontum's leadership team will remain in place; financial terms were not disclosed.

The IMA Group Acquires Orchard Medical Consulting

June 29, 2021

Healthcare Services

The IMA Group on June 29, 2021 acquired Orchard Medical Consulting to add nurse case and disability management capabilities to its clinical services portfolio. The acquisition — terms undisclosed — expands IMA's service offering and geographic coverage; Orchard will continue to operate under its current name and its leadership will remain in place.

The IMA Group Acquires Albuquerque Neuroscience, Inc.

September 9, 2021

Healthcare Services

The IMA Group has acquired Albuquerque Neuroscience, Inc., a clinical research site specializing in central nervous system (CNS) and general medical condition trials. The acquisition expands IMA Clinical Research's national footprint and deepens its capabilities in psychiatry, Alzheimer's disease and other neuropathic therapeutic areas; financial terms were not disclosed.

The IMA Group Acquires Accelemed Research Institute

April 11, 2023

Healthcare Services

The IMA Group (IMA Clinical Research) has acquired Accelemed Research Institute, a clinical research site in Austin, Texas, expanding IMA's footprint in the Southwest to more than 20 sites. The acquisition deepens IMA's capabilities in multi-therapeutic clinical trials—particularly cardiometabolic and GI indications—and keeps Accelemed operating under its current name with existing leadership retained.